Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?

by O. V. Averkov
Published 2010-04-01

The Role of Rivaroxaban in the Treatment of Patients with Stable Coronary Artery Disease

by O. V. Averkov
Published 2019-10-01

ANTI-THROMBOCYTIC DRUGS FOR ACUTE CORONARY SYNDROME: DIRECT COMPARISON OF HEMORRHAGIC SAFETY THROMBOCYTE P2Y12-RECEPTOR BLOCKERS TICAGRELOR AND CLOPIDROGEL (BASED ON PLATO STUDY RE...

by O. V. AVERKOV
Published 2016-12-01

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to red...

by O. V. Averkov
Published 2021-02-01

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES

by O. V. Averkov
Published 2016-01-01

IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?

by O. V. Averkov
Published 2011-08-01

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE

by O. V. Averkov
Published 2012-06-01

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013

by O. V. Averkov
Published 2013-02-01

ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE

by O. V. Averkov
Published 2012-08-01

MODERN APPROACHES TO ANTICOAGULANT THERAPY OF PULMONARY EMBOLISM: FOCUS ON RIVAROXABAN

by O. V. Averkov, V. I. Vechorko
Published 2017-11-01

Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?

by O. V. Averkov, V. I. Vechorko
Published 2018-09-01

Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients

by O. V. Averkov, V. I. Vechorko
Published 2019-09-01

Therapeutic potential of apixaban at different stages of management of patients with pulmonary thromboembolism

by O. V. Averkov, V. I. Vechorko, O. A. Shapsigova
Published 2019-01-01

THE PLACE FOR SYSTEMIC THROMBOLYSIS IN MODERN REPERFUSION METHODS FOR MYOCARDIAL INFARCTION

by O. V. Averkov, E. P. Pavlikova, E. E. Tyulkina
Published 2014-09-01

Venous thromboembolism in patients with heart failure

by O. V. Averkov, I. V. Shevchenko, T. Sh. Mirilashvili, Zh. D. Kobalava
Published 2011-08-01

COVID-19 infection after recent heart transplantation: a case report

by V. I. Vechorko, I. G. Gordeev, E. V. Gubareva, E. V. Ryndyaeva, O. V. Averkov
Published 2020-06-01

RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION

by L. N. Mishchenko, O. V. Averkov, I. G. Gordeev, E. E. Tyulkina, E. P. Pavlikova, N. N. Levchuk, I. G. Pletnikova
Published 2015-08-01

Differentiated approach in diagnostics, diagnosis formulation, case management and statistical accounting of type 2 myocardial infarction (Position Paper)

by O. V. Averkov, O. L. Barbarash, S. A. Boytsov, E. Yu. Vasilieva, O. M. Drapkina, A. S. Galyavich, M. Yu. Gilyarov, O. V. Zayratiants, L. V. Kakturskiy, Yu. A. Karpov, O. D. Mishnev, N. N. Nikulina, O. O. Orekhov, I. V. Samorodskaya, G. N. Soboleva, S. N. Cherkasov, R. M. Shakhnovich, A. S. Shilova, E. V. Shlyakhto, A. V. Shpektor, I. S. Yavelov, S. S. Yakushin
Published 2019-07-01

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized...

by S. N. Tereshchenko, M. G. Glezer, S. A. Abugov, O. V. Averkov, S. I. Antipov, A. S. Galyavich, M. Yu. Gilyarov, D. V. Duplyakov, A. A. Efremushkina, D. A. Zateyshchikov, V. V. Ivanenko, E. D. Kosmacheva, O. V. Krestyaninov, Yu. M. Lopatin, E. P. Panchenko, V. V. Ryabov, E. V. Samokhvalov, I. I. Staroverov, S. A. Ustyugov, A. V. Khripun, S. V. Shalaev, R. M. Shakhnovich, I. S. Yavelov, A. N. Yakovlev, S. S. Yakushin
Published 2019-11-01